Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0002007191-25-000031
Filing Date
2025-02-27
Accepted
2025-02-26 17:35:44
Documents
5
Period of Report
2025-02-25

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT OF FOREIGN ISSUER PURSUANT TO RULES 13A-16 AND 15D-16 AMENDMENTS block6k.htm 6-K 11783
2 EX-99.1 cblaunchpr.htm EX-99.1 14229
3 EX-99.2 blockclosepr.htm EX-99.2 13895
4 GRAPHIC image1.gif GRAPHIC 35096
5 GRAPHIC image1-1.gif GRAPHIC 35096
  Complete submission text file 0002007191-25-000031.txt   137900
Mailing Address 55 FLEMINGTON ROAD NORTH MELBOURNE C3 3051
Business Address 55 FLEMINGTON ROAD NORTH MELBOURNE C3 3051 61 3 9093 3855
Telix Pharmaceuticals Ltd (Filer) CIK: 0002007191 (see all company filings)

EIN.: 000000000 | State of Incorp.: C3 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-42128 | Film No.: 25671647
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)